Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia

Biochemical and Biophysical Research Communications
Junko SugataniMasao Miwa

Abstract

The UDP-glucuronosyltransferase UGT1A1 plays a critical role in the detoxification of potentially neurotoxic bilirubin by conjugating it with glucuronic acid. We identified a polymorphism that results in a T to G substitution at nucleotide number -3263 of the phenobarbital-responsive enhancer module of the UGT1A1 gene, thereby significantly decreasing transcriptional activity as indicated by the luciferase-reporter assay. At least one T-3263G allele was found in 21 of 25 subjects with mild hyperbilirubinemia (Gilbert's syndrome); this frequency (0.58) was significantly higher than that in normobilirubinemic controls (0.17; n = 8 of 27). Homozygous mutations in the TATA element (A[TA](7)TAA) or at nucleotide 211 of exon 1 (G to A substitution) were found in 5 and 2 of the hyperbilirubinemic group, respectively, while 12 of these subjects were double heterozygotes for the T-3263G and G211A mutations. Plasma total bilirubin levels in these double heterozygotes were significantly higher than those in control subjects carrying one or other of these mutations singly, indicating that compound heterozygous mutations may result in more strongly reduced UGT1A1 activity. Our results indicate that homozygosity and compound heterozygosity f...Continue Reading

References

Dec 1, 1972·Scandinavian Journal of Clinical and Laboratory Investigation·B LundhE Cavallin-Stahl
Nov 1, 1973·Proceedings of the Society for Experimental Biology and Medicine·T A BensingerM E Conrad
Nov 1, 1970·The Biochemical Journal·J D Ostrow, N H Murphy
Jan 15, 1971·Experientia·G IdeoN Dioguardi
Jun 5, 1969·The New England Journal of Medicine·M Black, B H Billing
Jan 1, 1982·Gastroenterologia Japonica·Y Adachi, T Yamamoto
Nov 2, 1995·The New England Journal of Medicine·P J BosmaR P Oude Elferink
Jan 22, 1998·Clinica Chimica Acta; International Journal of Clinical Chemistry·D J ClarkeB Burchell
Jun 25, 1999·Biochemical and Biophysical Research Communications·M CiottiI S Owens
May 9, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J SugataniT Sueyoshi

❮ Previous
Next ❯

Citations

Jul 16, 2009·Cancer Chemotherapy and Pharmacology·Y K PithavalaK J Klamerus
Apr 9, 2009·Pharmacogenetics and Genomics·Monica McGrathImmaculata De Vivo
Jan 7, 2009·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Glenn E PalomakiW David Dotson
Jun 10, 2010·BMC Gastroenterology·Katsuyuki MatsuiYoshihiro Takeuchi
Apr 2, 2008·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Kimie SaiHironobu Minami
Nov 3, 2011·PloS One·Masaya SugiyamaMasashi Mizokami
Jun 4, 2008·Pharmacogenomics·Christian P Strassburg
Mar 20, 2010·Pharmacogenomics·Yutaka Fujiwara, Hironobu Minami
May 31, 2011·Pharmacogenomics·Marianthi GeorgitsiGeorge P Patrinos
Oct 24, 2013·World Journal of Gastroenterology : WJG·Eva Sticova, Milan Jirsa
Nov 16, 2013·Journal of Perinatology : Official Journal of the California Perinatal Association·P K TiwariA Kumar
Nov 13, 2008·Critical Reviews in Clinical Laboratory Sciences·Christian P StrassburgUrsula Ehmer
May 19, 2011·Expert Opinion on Drug Metabolism & Toxicology·Kimie Sai, Yoshiro Saito
May 11, 2006·Drug Metabolism Reviews·Susumu Kodama, Masahiko Negishi
Oct 23, 2014·Drug Metabolism Reviews·Dong Gui HuPeter I Mackenzie
Nov 1, 2005·Drug Metabolism Reviews·Yuichi Ando, Yoshinori Hasegawa
Feb 2, 2016·Drug Metabolism Reviews·Dong Gui HuRobyn Meech
Nov 16, 2006·Liver International : Official Journal of the International Association for the Study of the Liver·Milan JirsaLibor Vitek
May 10, 2008·Journal of Chemotherapy·P BiasonG Toffoli
Jun 6, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Xi LiWei Zhang
Sep 6, 2012·Journal of Zhejiang University. Science. B·Wei-qin JiangLi-song Teng
Jun 19, 2016·Journal of Tropical Pediatrics·Rania Hosny TomerakMohamed Abdelhamid Yousef
Oct 26, 2016·AIDS Research and Treatment·Jacinta Nwamaka NwoguBabafemi Taiwo
Dec 15, 2016·Pharmacogenomics·Amy L PasternakCyrine E Haidar
Feb 19, 2017·Molecular Diagnosis & Therapy·Ann M MoyerLinnea M Baudhuin
Dec 22, 2009·Seminars in Fetal & Neonatal Medicine·Jon F Watchko, Zhili Lin
Oct 7, 2003·Oncogene·Apurva A DesaiMark J Ratain
Sep 19, 2006·Genetics in Medicine : Official Journal of the American College of Medical Genetics·John P A Ioannidis, Fotini K Kavvoura
Dec 18, 2013·Yonsei Medical Journal·Jason Yongha KimHyoung Doo Shin
Sep 29, 2015·PloS One·Bahram NamjouJohn B Harley
May 23, 2006·Pharmaceutical Research·Kouichi YoshinariMasao Miwa
Jul 22, 2006·Transplantation·Junichi KanekoMasatoshi Makuuchi

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.